- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-19-0041117

Qkur Pharmaceutical Private Limited
About Qkur Pharmaceutical Private Limited
Data last updated:
Qkur Pharmaceutical Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24110OR2020PTC034696.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rakesh Kumar Panda and Rajesh Kumar Panda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mig – II – S – 3/47 Bda Ph – II C.S.Pur, Bhubaneswar, Odisha, India – 751021.
As per the financials filed for FY 2025, the company reported a revenue of ₹69.01 Lakh, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹65,816 (net margin 1%) and EBITDA of ₹2.04 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years.
As per MCA filings, the company has open charges of ₹24 Lakh on record.
Qkur Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-19-0041117).
Company details
Recognitions & Rankings of Qkur Pharmaceutical
Contact details
Qkur Pharmaceutical Private Limited's registered office is in Bhubaneswar, Odisha.
- Registered AddressMig – II – S – 3/47 Bda Ph – II C.S.Pur, Bhubaneswar, Odisha, India – 751021
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Qkur Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Qkur Pharmaceutical Private Limited, buy the company report.
Financials of Qkur Pharmaceutical Private Limited
FY 2025 filings availableQkur Pharmaceutical Private Limited reported revenue of ₹69.01 Lakh (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 36% over three years, including 12% growth in the latest year. EBITDA rose 293% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹65,816 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Qkur Pharmaceutical Private Limited, buy the company report.
Board of directors of Qkur Pharmaceutical Private Limited
Qkur Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Kumar Panda | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
| Rajesh Kumar Panda | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Qkur Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MQG Commodities (India) Private Limited | ₹69.05 Lakh (FY 2023) | 12.0% | Mumbai, Maharashtra, India | |||
| CKV Sons Private Limited | ₹69.04 Lakh (FY 2021) | 3363.0% | Kozhikode, Kerala, India | |||
| Anaira's Jewels India Private Limited | ₹69.04 Lakh (FY 2017) | 2.0% | New Delhi, Delhi, India | |||
| Cielfoil (OPC) Private Limited | ₹69.02 Lakh (FY 2024) | 0.0% | Baddi, Himachal Pradesh, India | |||
| Tecex India Private Limited | ₹69.02 Lakh (FY 2024) | Chennai, Tamil Nadu, India | ||||
| Qkur Pharmaceutical Private Limitedthis company | ₹69.01 Lakh (FY 2025) | ₹65,816 | 1% | 12.0% | Bhubaneswar, Odisha, India | |
| Lumitis Green Technologies Private Limited | ₹69.01 Lakh (FY 2020) | -39.0% | Mumbai, Maharashtra, India | |||
| Kyros Engine Solutions Private Limited | ₹69 Lakh (FY 2025) | -81.0% | Navi Mumbai, Maharashtra, India | |||
| Aizen Lifestyle Private Limited | ₹68.98 Lakh (FY 2019) | -54.0% | Bengaluru, Karnataka, India | |||
| Alpha Qube Exports (OPC) Private Limited | ₹68.98 Lakh (FY 2024) | 103.0% | Bangalore, Karnataka, India | |||
| Risa Profiles Private Limited | ₹68.98 Lakh (FY 2023) | -57.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Qkur Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jan 2026 | 101230670 | Others | ₹24 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Qkur Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Qkur Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Qkur Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Qkur Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Rajesh Kumar Panda was appointed as Director on 04 Nov 2020.
Frequently asked questions
Qkur Pharmaceutical is an active private limited company based in Bhubaneswar, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 November 2020 (6+ years old) and is registered under CIN U24110OR2020PTC034696.
Qkur Pharmaceutical has 2 current directors:
- Rakesh Kumar Panda - Director
- Rajesh Kumar Panda - Director
The latest financial statements of Qkur Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Qkur Pharmaceutical is U24110OR2020PTC034696. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qkur Pharmaceutical was incorporated on 04 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Qkur Pharmaceutical by revenue are MQG Commodities (India) Private Limited, CKV Sons Private Limited, Anaira's Jewels India Private Limited, Cielfoil (OPC) Private Limited, Tecex India Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Rajesh Kumar Panda was appointed as Director on 04 Nov 2020. Rakesh Kumar Panda was appointed as Director on 04 Nov 2020.
Yes, Qkur Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-19-0041117).
The registered office of Qkur Pharmaceutical is at Mig – II – S – 347 Bda Ph – II C.S.Pur, Bhubaneswar, Odisha, India – 751021.
Qkur Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Qkur Pharmaceutical has open charges of ₹24 Lakh and no satisfied charges on record as per latest MCA filings.